Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Todd

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
Annals of the American Thoracic Society|November 12, 2024
Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryCoralynn Sack, Daniel M Wojdyla, Maeve G MacMurdo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 19, 2024
Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunctionJoanna M Schaenman, Stephen Samuel Weigt, Mengtong Pan, et al.
Lung|January 23, 2022
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry CohortJamie L Todd, Megan L Neely, Robert Overton, et al.
Respiratory Research|January 25, 2024
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO RegistryRoss Summer, Jamie L Todd, Megan L Neely, et al.
Ebiomedicine|December 3, 2025
Development and validation of a bronchoalveolar lavage genomic classifier for acute cellular rejectionS Samuel Weigt, Jin Zhou, Tomoki Okuno, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2022
Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft DysfunctionPierre H H Schneeberger, Chen Yang Kevin Zhang, Jessica Santilli, et al.
Respiratory Research|October 24, 2019
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO RegistryJamie L Todd, Megan L Neely, Robert Overton, et al.
Annals of the American Thoracic Society|May 5, 2016
Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung RecipientsAriss DerHovanessian, Jamie L Todd, Alice Zhang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 6, 2024
Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohortJeeyon G Rim, Anne S Hellkamp, Megan L Neely, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
BMC Pulmonary Medicine|March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohortJamie L Todd, Richard Vinisko, Yi Liu, et al.
Annals of the American Thoracic Society|November 12, 2024
Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) RegistryCoralynn Sack, Daniel M Wojdyla, Maeve G MacMurdo, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 19, 2024
Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunctionJoanna M Schaenman, Stephen Samuel Weigt, Mengtong Pan, et al.
Lung|January 23, 2022
Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry CohortJamie L Todd, Megan L Neely, Robert Overton, et al.
Respiratory Research|January 25, 2024
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO RegistryRoss Summer, Jamie L Todd, Megan L Neely, et al.
Ebiomedicine|December 3, 2025
Development and validation of a bronchoalveolar lavage genomic classifier for acute cellular rejectionS Samuel Weigt, Jin Zhou, Tomoki Okuno, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2022
Lung Allograft Microbiome Association with Gastroesophageal Reflux, Inflammation, and Allograft DysfunctionPierre H H Schneeberger, Chen Yang Kevin Zhang, Jessica Santilli, et al.
Respiratory Research|October 24, 2019
Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO RegistryJamie L Todd, Megan L Neely, Robert Overton, et al.
Annals of the American Thoracic Society|May 5, 2016
Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung RecipientsAriss DerHovanessian, Jamie L Todd, Alice Zhang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 6, 2024
Basiliximab induction immunosuppression and lung transplant outcomes: Propensity analysis in a multicenter cohortJeeyon G Rim, Anne S Hellkamp, Megan L Neely, et al.
Pageof 8